ROSEN, TOP GLOBAL INVESTMENT ADVISOR, Encourages Longeveron Inc. Investors to Seek Advice Before Important November 12 Deadline in Securities Class Action – LGVN |

NEW YORK – (BUSINESS WIRE) – November 7, 2021–

WHY: Rosen Law Firm, a global investor rights law firm, reminds buyers of securities of Longeveron Inc. (NASDAQ: LGVN): (1) in accordance with and / or traceable to offering documents issued under the Company’s initial public offer made on or around February 12, 2021 (the “IPO” or “the Offer”); and / or (2) between February 12, 2021 and August 12, 2021, both dates inclusive (the “Recourse Period”), of the material Principal applicant deadline of November 12, 2021.

SO WHAT: If you have purchased securities of Longeveron in accordance with and / or traceable to the IPO and / or during the Class Period, you may be entitled to compensation without payment of any fees or additional charges through ” a contingency fee agreement.

WHAT TO DO NEXT: To join the Longeveron class action lawsuit, go to or call Phillip Kim, Esq. toll free at 866-767-3653 or by emailing [email protected] or [email protected] for information on the class action. A class action has already been filed. If you want to serve as the principal applicant, you must move the court no later than November 12, 2021. A principal plaintiff is a representative party acting on behalf of the other members of the class to direct the litigation.

WHY THE ROSEN LAW: We encourage investors to select qualified advisors with a track record of success in leadership roles. Often, companies providing reviews do not have comparable experience, resources or peer recognition. Be wise in choosing the right lawyer. Rosen law firm represents investors around the world, focusing its practice on class actions in securities and derivative litigation between shareholders. Rosen law firm has secured the largest securities class action settlement against a Chinese company. Rosen law firm was ranked # 1 by ISS Securities Class Action Services for the number of securities class action settlements in 2017. The firm has been ranked in the top 4 every year since 2013 and has recovered hundreds millions of dollars for investors. In 2019 alone, the company raised more than $ 438 million for investors. In 2020, founding partner Laurence Rosen was appointed by law360 as the Titan of Plaintiffs’ Bar. Many of the firm’s lawyers have been recognized by Lawdragon and Super Lawyers.

CASE DETAILS: According to the lawsuit, the offer documents were prepared with negligence and, therefore, contained false statements of material facts or failed to state other facts necessary to make the statements made not misleading, and were not been prepared in accordance with the rules and regulations governing their preparation. In addition, throughout the Class Period, the defendants have made materially false and misleading representations regarding the Company’s business, operational and compliance policies. Specifically, the offer documents and the defendants made false and / or misleading statements and / or failed to disclose that: (1) Lomecel-B, a cell therapy product derived from medicinal signaling cells developed in cultured and obtained from the bone marrow of healthy young adult donors, was not as effective in treating aging frailty as the defendants had led investors to believe; (2) as a result, the clinical and commercial prospects of Lomecel-B with respect to the frailty of aging have been overestimated; (3) due to all of the above, Longeveron’s financial and business prospects have also been overstated; and (4) accordingly, the defendants’ public statements were materially false and misleading at all relevant times. When the real details entered the market, the lawsuit claims that investors have suffered damage.

To join the Longeveron class action lawsuit, go to or call Phillip Kim, Esq. toll free at 866-767-3653 or by emailing [email protected] or [email protected] for information on the class action.

No class has been certified. Until a group is certified, you are not represented by a lawyer unless you hire one. You can choose the lawyer of your choice. You can also remain an absent group member and do nothing at this point. The ability of an investor to participate in any potential future recovery does not depend on whether he or she is a lead applicant.

Follow us for updates on LinkedIn:, on Twitter:— entreprise or on Facebook:

Lawyer advertising. Previous results do not guarantee a similar result.

See the source version on

CONTACT: Laurence Rosen, Esq.

Phillip Kim, Esq.

Rosen Law Firm, Pennsylvania

275 Madison Avenue, 40th Floor

New York, New York 10016

Phone. : (212) 686-1060

Toll free: (866) 767-3653

Fax: (212) 202-3827

[email protected]

[email protected]

[email protected]



SOURCE: Rosen Law Firm

Copyright Business Wire 2021.

PUB: 07/11/2021 13:15 / DISC: 07/11/2021 13:16

Copyright Business Wire 2021.

About the author